Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Albireo Pharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- −3 vs. Q1 2022
- Shares held
- 17.8M
- +1.31M (+7.9%) vs. Q1 2022
- Total value
- $352.6M
- −$140.4M (−28.5%) vs. Q1 2022
- New holders
- 18
- 37 more added
- Sold out
- 21
- 33 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $44 |
| Q1 2026 | 1 | $44 |
| Q4 2025 | 1 | $44 |
| Q3 2025 | 1 | $744 |
| Q2 2025 | 1 | $744 |
| Q1 2025 | 1 | $744 |
| Q4 2024 | 1 | $744 |
| Q3 2024 | 1 | $744 |
| Q2 2024 | 1 | $744 |
| Q1 2024 | 1 | $744 |
| Q4 2023 | 1 | $744 |
| Q3 2023 | 1 | $744 |
| Q2 2023 | 1 | $756 |
| Q1 2023 | 3 | $2.04M |
| Q4 2022 | 96 | $401.7M |
| Q3 2022 | 109 | $372.0M |
| Q2 2022 | 103 | $352.6M |
| Q1 2022 | 109 | $495.4M |
| Q4 2021 | 96 | $362.5M |
| Q3 2021 | 94 | $477.0M |
| Q2 2021 | 99 | $546.1M |
| Q1 2021 | 100 | $589.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Albireo Pharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 1,424,343 | $28.3M | 0.00% | +515,615+56.7% | Added |
| Federated Hermes, Inc. | 2,255,124 | $44.8M | 0.12% | −103,500−4.4% | Reduced |
| Perceptive Advisors LLC | 2,360,139 | $46.9M | 1.47% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −194,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −169,600−100.0% | Sold out |
| Silver Oak Securities, Inc | 0 | $0 | 0.00% | −23,795−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −20,553−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −18,197−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,239−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −13,059−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,975−100.0% | Sold out |
| AdvisorShares Investments LLC | 0 | $0 | 0.00% | −9,066−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −8,288−100.0% | Sold out |
| Grimes & Company, Inc. | 0 | $0 | 0.00% | −8,191−100.0% | Sold out |
| Burney Co | 0 | $0 | 0.00% | −7,976−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −7,434−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −7,337−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −6,780−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −6,772−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,532−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −662−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −189−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |